Company / Total Debt
MoonLake Immunotherapeutics Total Debt History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$74.1M
FY2025
5-year range
$0 / $74.1M
FY2024-FY2025
Trend
-
vs FY2024
Sector context
#66 of 83
Health Care
What the data says
MoonLake Immunotherapeutics's total debt of $74M is lower than 80% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$74M in FY2025.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 83This company $74.1M Sector average $6.2B
▼
-98.8% below sector average
Key checks
Key Insights
- Ranks #66 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.1M | - |
| FY2024 | $0 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026